Criteria for the diagnosis of Guillain-Barré syndrome are reaffirmed. Electrodiagnostic criteria are expanded and specific detail added.

Introducción: El síndrome de Guillain- Barré ha sido asociado a la infección por el virus SARS-CoV-2 desde los inicios pandemia.

how to cite this article: yıldırım s. inan ar, gül lh, türk börü ü. an acute motor axonal neuropathy (aman) case with motor conductıon blocks in childhood. iran j child neurol. winter 2016; 10(1):65-69. abstract objective characterized with decreased compound muscle action potentials (cmap) and absence of demyelinating findings in electrophysiological studies, is a subtype of guillain-barre syn...

Recent studies of Guillain-Barré syndrome in adults have shown that the requirement for assisted ventilation correlates closely with a poor outcome, and the need for ventilation is now being used as an indication for plasmapheresis. As comparable studies in children have not been performed we reviewed our experience of patients who had Guillain-Barré syndrome severe enough to require assisted v...

This special commentary refers to ‘Epidemiological and cohort study finds no association between COVID-19 Guillain-Barré syndrome’ by Keddie et al. (doi:10.1093/brain/awaa433).

Background and Objectives: Guillain-Barre´ Syndrome (GBS) is an acute-onset, monophasic, immune-mediated polyneuropathy that often follows an antecedent infection. Special nutritional support has an important role in these patients. Methods: A 6 years old girl with GBS was admitted to PICU of Dr. Sheikh Children Hospital (Mashhad, Iran). Chief compliance for hospitalization was inability to w...

Treatment of Guillain-Barré syndrome with a standard course of high-dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc-receptor protects IgG from degradation, and a genetic polymorphism in its promoter region that influences the expression of Fc-receptor, may in part explain the var...

Treating Central Nervous System (CNS) neuro-inflammational disorders is of great importance. A key aspect of this treatment includes regulation of Cell-Mediated and humoral immune systems. Previous treatment mostly consisted of systemic immunosuppressive drugs. In addition to having adverse side effects, these drugs were also inefficient, such as methotrexate- Cyclophosphamide-Azathioprine. Rec...

Corticosteroids have been proved to be ineffective for Guillain-Barré syndrome, but the mechanism remains unknown. In a rabbit model of axonal Guillain-Barré syndrome, treatment with corticosteroids significantly reduced macrophage infiltration in the spinal ventral roots and the survival rate as well as clinical improvement. On 30(th) day after onset, there was significantly higher frequency o...

A patient with Guillain-Barré syndrome is reported on who responded favourably to a short course treatment with the novel immunosuppressant sodium fusidate (Fucidin), given at a daily dose of 1.5 g for one week. Along with prompt and clear cut clinical improvement, treatment with Fucidin was associated with a rapid decline in the blood concentrations of inflammatory cytokines presumably implica...